Update 03.16 PM EST: Adds comments from ResMed The U.S. Food and Drug Administration (FDA) on Thursday classified a product recall initiated by ResMed (NYSE:RMD) for its respiratory care devices ...
In the latest quarter, 5 analysts provided ratings for ResMed RMD, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their recent ratings, showcasing how ...
ResMed beat Wall Street estimates for quarterly profit on Thursday, driven by strong demand for its devices used for sleep apnea treatment. ResMed beats quarterly profit estimates on strong demand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results